全文获取类型
收费全文 | 5287篇 |
免费 | 371篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 160篇 |
妇产科学 | 97篇 |
基础医学 | 1034篇 |
口腔科学 | 65篇 |
临床医学 | 424篇 |
内科学 | 1071篇 |
皮肤病学 | 149篇 |
神经病学 | 550篇 |
特种医学 | 141篇 |
外科学 | 448篇 |
综合类 | 15篇 |
一般理论 | 1篇 |
预防医学 | 460篇 |
眼科学 | 82篇 |
药学 | 349篇 |
中国医学 | 4篇 |
肿瘤学 | 589篇 |
出版年
2023年 | 28篇 |
2022年 | 48篇 |
2021年 | 86篇 |
2020年 | 55篇 |
2019年 | 120篇 |
2018年 | 127篇 |
2017年 | 82篇 |
2016年 | 104篇 |
2015年 | 137篇 |
2014年 | 164篇 |
2013年 | 246篇 |
2012年 | 389篇 |
2011年 | 408篇 |
2010年 | 201篇 |
2009年 | 236篇 |
2008年 | 375篇 |
2007年 | 393篇 |
2006年 | 396篇 |
2005年 | 378篇 |
2004年 | 412篇 |
2003年 | 343篇 |
2002年 | 330篇 |
2001年 | 46篇 |
2000年 | 32篇 |
1999年 | 56篇 |
1998年 | 80篇 |
1997年 | 46篇 |
1996年 | 48篇 |
1995年 | 57篇 |
1994年 | 36篇 |
1993年 | 28篇 |
1992年 | 15篇 |
1991年 | 23篇 |
1990年 | 16篇 |
1989年 | 14篇 |
1988年 | 8篇 |
1987年 | 8篇 |
1986年 | 9篇 |
1985年 | 8篇 |
1984年 | 9篇 |
1983年 | 10篇 |
1982年 | 9篇 |
1981年 | 11篇 |
1980年 | 9篇 |
1979年 | 6篇 |
1976年 | 3篇 |
1975年 | 3篇 |
1974年 | 5篇 |
1970年 | 2篇 |
1957年 | 2篇 |
排序方式: 共有5670条查询结果,搜索用时 0 毫秒
71.
Anne-Esther Breyton Aurélie Goux Stéphanie Lambert-Porcheron Alexandra Meynier Monique Sothier Laurie VanDenBerghe Olivier Brack Emmanuel Disse Martine Laville Sophie Vinoy Julie-Anne Nazare 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2021,31(1):237-246
Background and aimsIn type 2 diabetes (T2D) patients, the reduction of glycemic variability and postprandial glucose excursions is essential to limit diabetes complications, beyond HbA1c level. This study aimed at determining whether increasing the content of Slowly Digestible Starch (SDS) in T2D patients’ diet could reduce postprandial hyperglycemia and glycemic variability compared with a conventional low-SDS diet.Methods and resultsFor this randomized cross-over pilot study, 8 subjects with T2D consumed a controlled diet for one week, containing starchy products high or low in SDS. Glycemic variability parameters were evaluated using a Continuous Glucose Monitoring System.Glycemic variability was significantly lower during High-SDS diet compared to Low-SDS diet for MAGE (Mean Amplitude of Glycemic Excursions, p < 0.01), SD (Standard Deviation, p < 0.05), and CV (Coefficient of Variation, p < 0.01). The TIR (Time In Range) [140–180 mg/dL[ was significantly higher during High-SDS diet (p < 0.0001) whereas TIRs ≥180 mg/dL were significantly lower during High-SDS diet. Post-meals tAUC (total Area Under the Curve) were significantly lower during High-SDS diet.ConclusionOne week of High-SDS Diet in T2D patients significantly improves glycemic variability and reduces postprandial glycemic excursions. Modulation of starch digestibility in the diet could be used as a simple nutritional tool in T2D patients to improve daily glycemic control.Registration numberin clinicaltrials.gov: NCT 03289494. 相似文献
72.
73.
Marie Georgelin-Gurgel Franck Diemer Emmanuel Nicolas Martine Hennequin 《Journal of endodontics》2009,35(1):19-22
This observational study compared physiologic and psychological indicators of stress between two groups of 30 healthy patients undergoing either surgical or nonsurgical endodontic treatments. Heart rate (HR), systolic blood pressure (SBP), and diastolic blood pressure were monitored during care sessions. The patients were asked to score their anxiety before treatment and to report pain, stress, and/or discomfort experienced during care. Variations in HR and SBP were significantly dependent on treatment group (HR: F = 6, p < 0.001; SBP: F = 4, p = 0.05). Intergroup differences increased during the active steps of the treatment, such as local anesthesia, rotary instrumentation, periradicular curettage, root filling, and field removal. Moreover, the level of stress experienced during the care procedure was correlated to the level of anticipated anxiety in both groups. This study raises questions on the indications for anxiolysis or sedation in endodontic patients as a means of preventing the neurophysiologic consequences of stress. 相似文献
74.
Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. 总被引:7,自引:0,他引:7
Filip Baert Alain Schmit Geert D'Haens Franceska Dedeurwaerdere Edouard Louis Marc Cabooter Martine De Vos Fernand Fontaine Serge Naegels Piet Schurmans Hedwig Stals Karel Geboes Paul Rutgeerts 《Gastroenterology》2002,122(1):20-25
BACKGROUND & AIMS: Collagenous colitis (CC) is a well-described entity causing chronic diarrhea and characteristic histologic findings. Several treatment options have been suggested, but no controlled data are available. We conducted a placebo-controlled trial to show the clinical and histologic effects of budesonide in CC. METHODS: Twenty-eight patients were randomly assigned to receive placebo (n = 14) or budesonide 9 mg daily (n = 14) for 8 weeks. Patients were evaluated clinically, and blinded biopsy specimens were analyzed from fixed locations at weeks 0 and 8. Clinical response was defined as a decrease of at least 50% in the disease activity score (number of bowel movements in the last 7 days). At week 8, nonresponders received open-label budesonide for the next 8-week period; responders discontinued treatment and were followed up. RESULTS: Three patients discontinued the study prematurely. Intention-to-treat analysis showed clinical response in 8 of 14 patients in the budesonide group compared with 3 of 14 responders for placebo (P = 0.05) after 8 weeks of blinded therapy, together with improved stool consistency. Histologically, there was no change in the mean thickness of the collagen band but a significant decrease of the lamina propria infiltrate in the budesonide group (P < 0.001). CONCLUSIONS: Budesonide is efficacious in inducing short-term clinical response in CC with significant reduction of the histologic infiltrate in the lamina propria. 相似文献
75.
Laurent C Bourgeois A Faye MA Mougnutou R Seydi M Gueye M Liégeois F Kane CT Butel C Mbuagbaw J Zekeng L Mboup S Mpoudi-Ngolé E Peeters M Delaporte E 《The Journal of infectious diseases》2002,186(4):486-492
To compare human immunodeficiency virus (HIV) type 1 disease progression in patients infected by the predominant strain circulating recombinant form (CRF) 02_AG in western and west-central Africa and in patients infected by other strains, a prospective multicenter cohort study was conducted in Cameroon and Senegal. Among the 335 patients, a broad HIV-1 group M subtype diversity was observed in the envelope V3-V5 region, but strain CRF02_AG predominated in both Cameroon and Senegal (61.2% and 62.9%, respectively; P<.8). Multivariate analyses showed no difference between patients infected by CRF02 strains and those infected by other strains in terms of survival (adjusted hazards ratio [HR], 1.16; 95% confidence interval [CI], 0.76-1.78; P=.5), clinical disease progression (HR, 0.79; 95% CI, 0.50-1.25; P=.3), or square root CD4 cell decline (regression coefficient, -0.01; 95% CI, -0.82 to 0.81; P=.9). This study suggests that the predominance of HIV-1 CRF02_AG strain in western and west-central Africa should have no major clinical consequences. 相似文献
76.
77.
Merel Klaassens Deborah Morrogh Elisabeth M Rosser Fatima Jaffer Maaike Vreeburg Levinus A Bok Tim Segboer Martine van Belzen Ros M Quinlivan Ajith Kumar Jane A Hurst Richard H Scott 《European journal of human genetics : EJHG》2015,23(5):610-615
De novo monoallelic variants in NFIX cause two distinct syndromes. Whole gene deletions, nonsense variants and missense variants affecting the DNA-binding domain have been seen in association with a Sotos-like phenotype that we propose is referred to as Malan syndrome. Frameshift and splice-site variants thought to avoid nonsense-mediated RNA decay have been seen in Marshall–Smith syndrome. We report six additional patients with Malan syndrome and de novo NFIX deletions or sequence variants and review the 20 patients now reported. The phenotype is characterised by moderate postnatal overgrowth and macrocephaly. Median height and head circumference in childhood are 2.0 and 2.3 standard deviations (SD) above the mean, respectively. There is overlap of the facial phenotype with NSD1-positive Sotos syndrome in some cases including a prominent forehead, high anterior hairline, downslanting palpebral fissures and prominent chin. Neonatal feeding difficulties and/or hypotonia have been reported in 30% of patients. Developmental delay/learning disability have been reported in all cases and are typically moderate. Ocular phenotypes are common, including strabismus (65%), nystagmus (25% ) and optic disc pallor/hypoplasia (25%). Other recurrent features include pectus excavatum (40%) and scoliosis (25%). Eight reported patients have a deletion also encompassing CACNA1A, haploinsufficiency of which causes episodic ataxia type 2 or familial hemiplegic migraine. One previous case had episodic ataxia and one case we report has had cyclical vomiting responsive to pizotifen. In individuals with this contiguous gene deletion syndrome, awareness of possible later neurological manifestations is important, although their penetrance is not yet clear. 相似文献
78.
79.
Balancing research interests and patient interests: A qualitative study into the intertwinement of care and research in paediatric oncology 下载免费PDF全文
80.
Mapmodulin: A possible modulator of the interaction of microtubule-associated proteins with microtubules 下载免费PDF全文
Nirit Ulitzur Martine Humbert Suzanne R. Pfeffer 《Proceedings of the National Academy of Sciences of the United States of America》1997,94(10):5084-5089
We have purified and characterized a 31-kDa protein named mapmodulin that binds to the microtubule-associated proteins (MAPs) MAP2, MAP4, and tau. Mapmodulin binds free MAPs in strong preference to microtubule-associated MAPs, and appears to do so via the MAP’s tubulin-binding domain. Mapmodulin inhibits the initial rate of MAP2 binding to microtubules, a property that may allow mapmodulin to displace MAPs from the path of organelles translocating along microtubules. In support of this possibility, mapmodulin stimulates the microtubule- and dynein-dependent localization of Golgi complexes in semi-intact CHO cells. To our knowledge, mapmodulin represents the first example of a protein that can bind and potentially regulate multiple MAP proteins. 相似文献